Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 04/21 10:24:28 am
25710 ILa   +2.43%
03:45pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
12:49pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
12:02pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
04:01p ACTIVE BIOTECH : Teva and Active Biotech Announce First Patient Enrolled in Phas..
03:45pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
12:49pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
12:02pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
11:07aDJMylan to Make Formal Bid for Perrigo -- 3rd Update
10:56aDJMylan to Make Formal Bid for Perrigo -- 2nd Update
10:37aDJMylan to Make Formal Bid for Perrigo -- Update
10:36aDJMylan Raises Bid for Generic Drug Maker Perrigo
10:22aDJMylan to Make Formal Bid for Perrigo
04/23 TEVA PHARMACEUTICAL : and Active Biotech Announce First Patient Enrolled in Phas..
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF